The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation

This publication has 130 references indexed in Scilit:

• Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
  American Heart Journal, 2013
• Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
  The Lancet, 2012
• Antiarrhythmic Drug Therapy for Atrial Fibrillation
  Circulation, 2012
• Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation
  JACC, 2011
• Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study
  EP Europace, 2011
• Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial)
  The American Journal of Cardiology, 2011
• Can we improve outcomes in AF patients by early therapy?
  BMC Medicine, 2009
• Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the RAte Control versus Electrical cardioversion (RACE) study
  American Heart Journal, 2005
• Amiodarone versus Sotalol for Atrial Fibrillation
  New England Journal of Medicine, 2005
• Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
  American Heart Journal, 2005